Register entry
- Registered sites
- 1
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 1
- Base
- Belgium
Authorisation
Registered operations
Analytical testing1Labelling1Finished drug manufacture1Packaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Purna Pharmaceuticals NV | Rijksweg 17, Puurs, 2870, Belgium (BEL) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3003848224372126946 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | vamorolone | suspension | 62450-003DRUG FOR FURTHER PROCESSING |
Compare
Comparable companies in Belgium
- Minakem High Potent1 site · 4 NDC
- argenx BV1 site · 3 NDC
- Henogen1 site · 1 NDC
- Kaneka Eurogentec SA1 site · 1 NDC
- UCB, Inc.2 sites · 65 NDC
- Ajinomoto OmniChem N.V.4 sites · 14 NDC
Enquiry
Common questions
- Is Purna Pharmaceuticals NV FDA approved?
- Purna Pharmaceuticals NV holds 1 FDA-registered establishment in Belgium. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Purna Pharmaceuticals NV's drugs manufactured?
- The FDA register lists Puurs. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
- What drugs does Purna Pharmaceuticals NV make?
- 1 product is listed under Purna Pharmaceuticals NV in the openFDA NDC Directory, most often as suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.